Canada strives for impartiality in reassessment of suspended device licences
This article was originally published in SRA
Executive Summary
Health Canada has implemented operational changes to the way it provides device manufacturers with an "opportunity to be heard" with regard to the suspension of a product licence as well as to its process for reassessing a suspended licence1.